Food and Drug Administration (FDA) in early June and sold under the brand name Wegovy, is for chronic weight management in clinically obese adults, who are defined as those with a body mass index (BMI) of 30 or greater
Before any medication is started, patients go through a full metabolic workup, relevant lab testing, and a real planning conversation about goals, expectations, and potential obstacles
It usually takes about 6 to 12 months after the heaviest shedding stops to see a noticeable difference
The real work begins in Phase 2
Drug interactions and side effects of Semaglutide In studying the effects of semaglutide treatment on the pharmacokinetics metformin, warfarin, atorvastatin and digoxin, it was found that this GLP-1 analog did not affect such properties to a clinically relevant degree (Hausner et al., 2017)